Discontinuation report HYCAMTIN

Last updated on 2019-06-11 History
Report ID 8129
Drug Identification Number 02231116
Brand name HYCAMTIN
Common or Proper name Hycamtin4mg/Vials 5's
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TOPOTECAN
Strength(s) 4MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 4mg x 5
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-05-31
Actual discontinuation date 2019-06-10
Remaining supply date 2019-05-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Inventory on hand - expiration date 30.11.2019.
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2019-06-11 English Compare
v17 2019-06-10 French Compare
v16 2019-06-10 English Compare
v15 2019-06-10 English Compare
v14 2019-03-08 French Compare
v13 2019-03-08 English Compare
v12 2019-02-11 French Compare
v11 2019-02-11 English Compare
v10 2019-02-11 English Compare
v9 2017-09-26 French Compare
v8 2017-09-26 English Compare
v7 2017-06-15 French Compare
v6 2017-06-15 English Compare
v5 2017-04-28 French Compare
v4 2017-04-28 English Compare
v3 2017-04-26 French Compare
v2 2017-04-26 French Compare
v1 2017-04-26 English Compare

Showing 1 to 18 of 18